Melinda Jane Braskett MD
Medical Director, Food and Drug Allergy Care Center; Assistant Professor, Clinical Immunology and Allergy, UCLA School of Medicine
Join to View Full Profile
4650 W Sunset BlvdLos Angeles, CA 90027
Phone+1 323-361-2501
Fax+1 323-361-1191
Dr. Braskett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Allergy and Immunology, 2006 - 2008
Children's Hospital Los AngelesResidency, Pediatrics, 2001 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 2 citationsAdvances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Im...Benjamin L Wright, Juan Pablo Abonia, Edsel M Abud, Seema S Aceves, Steven J Ackerman
The Journal of Allergy and Clinical Immunology. 2024-10-01 - Ustekinumab for psoriasis and psoriatic arthritis in adolescents with 22q11.2 deletion syndrome.Belina Y Yi, Sonia Kamath, Minnelly Luu, Michal Cidon, Melinda Braskett
The Journal of Allergy and Clinical Immunology. in Practice. 2023-12-01 - 2 citationsThe Brief Case: Vaccine strain herpes zoster ophthalmicus and meningoencephalitis in an immunocompetent child.Katherine Rand, Kaidi He, Jennifer Dien Bard, Melinda Braskett, Sindhu Mohandas
Journal of Clinical Microbiology. 2023-08-23
Press Mentions
Bryn Pharma Announces Completion of Its Pivotal Study Comparing UTULY™ Epinephrine Intranasal Spray vs. 0.3 Mg Epinephrine Autoinjector for the Treatment of AnaphylaxisSeptember 13th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
